ATAD2 is Highly Expressed in Ovarian Carcinomas and Indicates Poor Prognosis
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ATAD2 is Highly Expressed in Ovarian Carcinomas and Indicates Poor Prognosis
Authors
Keywords
-
Journal
Asian Pacific Journal of Cancer Prevention
Volume 15, Issue 6, Pages 2777-2783
Publisher
Asian Pacific Organization for Cancer Prevention
Online
2014-07-10
DOI
10.7314/apjcp.2014.15.6.2777
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Expression of Nuclear Factor Kappa B (NF-κB) as a Predictor of Poor Pathologic Response to Chemotherapy in Patients with Locally Advanced Breast Cancer
- (2014) Yan Wisnu Prajoko et al. Asian Pacific Journal of Cancer Prevention
- DNA Hypermethylation of Cell Cycle (p15 and p16) and Apoptotic (p14, p53, DAPK and TMS1) Genes in Peripheral Blood of Leukemia Patients
- (2014) Khaldon Bodoor et al. Asian Pacific Journal of Cancer Prevention
- Integrated Genomic Analysis of the 8q24 Amplification in Endometrial Cancers Identifies ATAD2 as Essential to MYC-Dependent Cancers
- (2013) Maria B. Raeder et al. PLoS One
- Biomarkers for Screening, Diagnosis, and Monitoring of Ovarian Cancer
- (2012) E. Kobayashi et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Identification of Tumor Suppressors and Oncogenes from Genomic and Epigenetic Features in Ovarian Cancer
- (2011) Kazimierz O. Wrzeszczynski et al. PLoS One
- Early Diagnosis of Ovarian Carcinoma: Is a Solution in Sight?
- (2011) Amelie M. Lutz et al. RADIOLOGY
- ANCCA/ATAD2 Overexpression Identifies Breast Cancer Patients with Poor Prognosis, Acting to Drive Proliferation and Survival of Triple-Negative Cells through Control of B-Myb and EZH2
- (2010) E. V. Kalashnikova et al. CANCER RESEARCH
- Chromatin Loading of E2F-MLL Complex by Cancer-Associated Coregulator ANCCA via Reading a Specific Histone Mark
- (2010) A. S. Revenko et al. MOLECULAR AND CELLULAR BIOLOGY
- Deregulated E2F and the AAA+ Coregulator ANCCA Drive Proto-Oncogene ACTR/AIB1 Overexpression in Breast Cancer
- (2010) E. Y.C. Hsia et al. MOLECULAR CANCER RESEARCH
- Estrogen Receptor Subtypes in Ovarian Cancer
- (2010) Karen K. L. Chan et al. OBSTETRICS AND GYNECOLOGY
- Functional characterization of ATAD2 as a new cancer/testis factor and a predictor of poor prognosis in breast and lung cancers
- (2010) C Caron et al. ONCOGENE
- Änderungen der TNM-Klassifikation gynäkologischer Tumoren
- (2010) L.-C. Horn et al. PATHOLOGE
- Androgen-Induced Coactivator ANCCA Mediates Specific Androgen Receptor Signaling in Prostate Cancer
- (2009) J. X. Zou et al. CANCER RESEARCH
- ATAD2 Is a Novel Cofactor for MYC, Overexpressed and Amplified in Aggressive Tumors
- (2009) M. Ciro et al. CANCER RESEARCH
- HE4 as a biomarker for ovarian and endometrial cancer management
- (2009) Jinping Li et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- The early detection of ovarian cancer: from traditional methods to proteomics. Can we really do better than serum CA-125?
- (2008) Vladimir Nossov et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Comparison of prognostic gene expression signatures for breast cancer
- (2008) Benjamin Haibe-Kains et al. BMC GENOMICS
- Diagnostic Markers for Early Detection of Ovarian Cancer
- (2008) I. Visintin et al. CLINICAL CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started